Lead Product(s) : Levotofisopam
Therapeutic Area : Rheumatology
Study Phase : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Levotofisopam is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Hyperuricemia.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
January 27, 2012
Lead Product(s) : Levotofisopam
Therapeutic Area : Rheumatology
Highest Development Status : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
